HK1024006A1 - Peptide as diagnostic and therapeutic agent for autoimmune diseases - Google Patents

Peptide as diagnostic and therapeutic agent for autoimmune diseases

Info

Publication number
HK1024006A1
HK1024006A1 HK00103326A HK00103326A HK1024006A1 HK 1024006 A1 HK1024006 A1 HK 1024006A1 HK 00103326 A HK00103326 A HK 00103326A HK 00103326 A HK00103326 A HK 00103326A HK 1024006 A1 HK1024006 A1 HK 1024006A1
Authority
HK
Hong Kong
Prior art keywords
peptide
diagnostic
therapeutic agent
autoimmune diseases
autoimmune
Prior art date
Application number
HK00103326A
Other languages
English (en)
Inventor
Gerhild Wildner
Original Assignee
Gerhild Wildner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gerhild Wildner filed Critical Gerhild Wildner
Publication of HK1024006A1 publication Critical patent/HK1024006A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4741—Keratin; Cytokeratin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK00103326A 1996-09-18 2000-06-01 Peptide as diagnostic and therapeutic agent for autoimmune diseases HK1024006A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19638108 1996-09-18
PCT/EP1997/005124 WO1998012221A1 (de) 1996-09-18 1997-09-18 Peptide als diagnostikum und therapeutikum für autoimmunerkrankungen

Publications (1)

Publication Number Publication Date
HK1024006A1 true HK1024006A1 (en) 2000-09-29

Family

ID=7806049

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00103326A HK1024006A1 (en) 1996-09-18 2000-06-01 Peptide as diagnostic and therapeutic agent for autoimmune diseases

Country Status (8)

Country Link
EP (1) EP0950065B1 (xx)
JP (2) JP4615630B2 (xx)
CN (1) CN1227263C (xx)
AU (1) AU4459797A (xx)
DE (1) DE59709363D1 (xx)
ES (1) ES2193401T3 (xx)
HK (1) HK1024006A1 (xx)
WO (1) WO1998012221A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810099D0 (en) * 1998-05-11 1998-07-08 Isis Innovation Novel molecule and diagnostic method
WO2002014870A2 (en) * 2000-08-14 2002-02-21 Akzo Nobel N.V. Use of antibodies against specific mhc-peptide complexes
WO2009090651A2 (en) * 2008-01-15 2009-07-23 Technion Research And Development Foundation Ltd. Major histocompatibility complex hla-b2705 ligands useful for therapy and diagnosis
EP3016968B1 (en) * 2013-07-01 2019-06-26 Newsouth Innovations Pty Limited Diagnosis and treatment of autoimmune diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888512A (en) * 1987-01-30 1999-03-30 Board Of Trustees Of The Leland Stanford Junior University Lymphocyte activity regulation by HLA peptides
US5719064A (en) * 1992-08-31 1998-02-17 Oklahoma Medical Research Foundation Peptide diagnostics and therapeutics for spondyloarthropathies
CA2176208A1 (en) * 1993-11-10 1995-05-18 Carol Clayberger Surface membrane proteins and their effect on immune response

Also Published As

Publication number Publication date
EP0950065B1 (de) 2003-02-19
CN1227263C (zh) 2005-11-16
CN1237981A (zh) 1999-12-08
WO1998012221A1 (de) 1998-03-26
AU4459797A (en) 1998-04-14
JP2010235607A (ja) 2010-10-21
DE59709363D1 (de) 2003-03-27
JP2001504451A (ja) 2001-04-03
EP0950065A1 (de) 1999-10-20
ES2193401T3 (es) 2003-11-01
JP4615630B2 (ja) 2011-01-19

Similar Documents

Publication Publication Date Title
EP1173191A4 (en) NOVEL ANTI-ANGIOGENIC PEPTIDE AGENTS, USE OF THE SAME FOR THERAPY AND DIAGNOSIS
ZA962527B (en) Radiolabeled peptides for diagnosis and therapy
EP0959908A4 (en) NOVEL CONTRAST MEDIA CONTAINING A TARGETING AGENT FOR DIAGNOSTIC AND THERAPEUTIC USE
GB9601724D0 (en) Therapeutic agents
EP0964250A4 (en) MEDICINES FOR THE DIAGNOSIS OF AUTOIMMUNE DISEASES
AU3816697A (en) Conservin compositions and therapeutic and diagnostic uses therefor
GB9600235D0 (en) Therapeutic agents
EP0831793A4 (en) PROTEIN PARTICLES FOR THERAPEUTIC AND DIAGNOSTIC USE
HUP9900147A3 (en) Therapeutic agents and autoimmune diseases
IL129024A0 (en) Use of proteins as agent against autoimmune diseases
AU2976597A (en) Autoimmune disease therapeutic agent
GB9419021D0 (en) Therapeutic protein
AU7141698A (en) Secreted protein ssp-1 compositions and therapeutic and diagnostic uses therefor
IL121329A (en) Pharmaceutical composition for the treatment of cancer comprising somatostatin2 and other peptides
AU6517398A (en) Therapeutic agent for autoimmune diseases
HK1024006A1 (en) Peptide as diagnostic and therapeutic agent for autoimmune diseases
HUP9801680A3 (en) Peptides and remedy for autoimmune diseases comprising the same
GB9621825D0 (en) Microparticles and their use as therapeutic vehicles
GB9620777D0 (en) Therapeutic use
EP0878200A4 (en) THERAPEUTIC AGENT FOR OPHTHALMIC DISEASES
IL112681A0 (en) Opioid peptides for the treatment of pain and use thereof
ZA976547B (en) Lipid-binding proteins and their therapeutic and diagnostic use
GB9617346D0 (en) Therapeutic methods and compositions for use therein
AUPO338496A0 (en) Therapeutic and diagnostic agents
HUP9904268A3 (en) Use of proteins as agents against autoimmune diseases

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20170917